Compounds > durapatite
Page last updated: 2024-08-21

durapatite and Prostatic Neoplasms

durapatite has been researched along with Prostatic Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's8 (66.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Du, W; Gao, S; Gong, W; Li, H; Lin, J; Lin, Y; Shu, Z; Yu, Y; Zheng, M1
Barbanente, A; Esposti, LD; Iafisco, M; Leeuwenburgh, SCG; Margiotta, N; Nadar, RA; Palazzo, B; van den Beucken, JJJP1
Cruz-Neves, S; Graça, I; Jerónimo, C; Monteiro, FJ; Ribeiro, N; Sousa, SR1
Guo, B; Li, F; Liang, Z; Liu, J; Liu, Z; Wang, H; Xu, L; Yun, W; Zhang, L; Zhao, X1
Burton, LJ; Campbell, T; Dougan, J; Hawsawi, O; Henderson, VM; Howard, SM; Odero-Marah, VA; Trice, K1
Arpinati, L; Caudron, E; Cebrián-Torrejón, G; de Miguel, L; Desmaele, D; Doménech-Carbó, A; Noiray, M; Ponchel, G; Popa, I1
Cunningham, D; Liu, S; Mei, J; Parajuli, KR; Wang, G; You, Z; Zhang, C; Zhang, Q1
De Marzo, AM; Isaacs, WB; Sfanos, KS; Wilson, BA1
Fang, Y; Gao, X; Guo, W; Ling, Y; Liu, W; Luo, Y; Pang, J; Wei, K; Wen, X1
Gao, LF; Guo, BF; Li, X; Li, XJ; Li, Y; Liang, ZW; Yang, BX; Yu, H; Zhang, L; Zhao, LJ; Zhao, XJ1
Ashino, H; Dozono, H; Hino, A; Kasahara, H; Minamizawa, T; Oshikiri, S; Satake, M; Suwada, J; Suzuki, K1
Dai, J; Keller, ET; Lin, DL; Morris, MD; Patel, AH; Rohn, E; Tarnowski, CP; Zhang, J1

Other Studies

12 other study(ies) available for durapatite and Prostatic Neoplasms

ArticleYear
Quantitative and direct serum albumin detection by label-free SERS using tunable hydroxyapatite nanostructure for prostate cancer detection.
    Analytica chimica acta, 2022, Aug-15, Volume: 1221

    Topics: Durapatite; Early Detection of Cancer; Humans; Male; Nanostructures; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Serum Albumin; Spectrum Analysis, Raman

2022
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
    Journal of materials chemistry. B, 2020, 04-08, Volume: 8, Issue:14

    Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Coculture Techniques; Drug Liberation; Drug Screening Assays, Antitumor; Durapatite; Humans; Kinetics; Male; Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Selenium; Stem Cells; Surface Properties; Tumor Cells, Cultured

2020
Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold.
    Journal of biomedical materials research. Part A, 2017, Volume: 105, Issue:7

    Topics: Animals; Bone and Bones; Cell Line, Tumor; Durapatite; Humans; Male; Mice; Nanostructures; Neoplasm Proteins; Osteonectin; Prostatic Neoplasms; Tissue Scaffolds

2017
Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle‑delivered short hairpin RNAs against Stat3.
    Molecular medicine reports, 2017, Volume: 16, Issue:1

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Durapatite; Gene Expression Regulation, Neoplastic; Humans; Male; Nanoparticles; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor

2017
Cancer-bone microenvironmental interactions promotes STAT3 signaling.
    Molecular carcinogenesis, 2019, Volume: 58, Issue:8

    Topics: Animals; Bone and Bones; Bone Neoplasms; Calcium; Cathepsin L; Cell Line, Tumor; Cell Movement; Cell Proliferation; Durapatite; Egtazic Acid; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Pyridines; RNA Interference; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; STAT3 Transcription Factor; Tumor Microenvironment; Tyrphostins

2019
Osteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery.
    Pharmaceutical research, 2015, Volume: 32, Issue:5

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Delayed-Action Preparations; Durapatite; Humans; Male; Nanoparticles; Polyglutamic Acid; Prostate; Prostatic Neoplasms

2015
Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.
    The Prostate, 2016, Volume: 76, Issue:15

    Topics: Animals; Antimitotic Agents; Apoptosis; Bone Neoplasms; Calcium; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Durapatite; Humans; Ions; Male; Mice; Microtubules; Oligopeptides; Phosphates; Prostatic Neoplasms; Tibia; Tubulin Modulators; Tumor Burden; Xenograft Model Antitumor Assays

2016
Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Mar-03, Volume: 106, Issue:9

    Topics: Acute-Phase Proteins; Calcium Phosphates; Durapatite; Humans; Inflammation; Lactoferrin; Male; Prostatic Diseases; Prostatic Neoplasms; Tandem Mass Spectrometry

2009
Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Oct-15, Volume: 147, Issue:2

    Topics: Androgens; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 2; Cell Cycle; Cell Line, Tumor; Cell Survival; Cysteine Endopeptidases; Docetaxel; Drug Carriers; Drug Compounding; Durapatite; Enzyme Activation; Flow Cytometry; Humans; Male; Membrane Potential, Mitochondrial; Nanoparticles; Oleic Acid; Particle Size; Prostatic Neoplasms; RNA, Small Interfering; Taxoids

2010
Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.
    Asian journal of andrology, 2011, Volume: 13, Issue:3

    Topics: Animals; Apoptosis; Cell Line, Tumor; Durapatite; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Plasmids; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor

2011
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:7

    Topics: Animals; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Chelating Agents; Diphosphonates; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Osteolysis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results

2011
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
    The Prostate, 2001, May-15, Volume: 47, Issue:3

    Topics: Anthraquinones; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Neoplasms; Calcinosis; Calcium; Cell Division; Core Binding Factor Alpha 1 Subunit; Durapatite; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Male; Neoplasm Proteins; Osteoblasts; Osteoprotegerin; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Staining and Labeling; Transcription Factors; Transforming Growth Factor beta; Tumor Cells, Cultured

2001